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A fibroepithelial lesion is a biphasic coproliferation of
epithelium and stroma. These lesions make up a significant
number of lesions encountered in both breast screening and
symptomatic practice. Fibroepithelial lesions encompass
both benign (fibroadenoma, lactational adenoma, and tubular
adenoma) and malignant entities (phyllodes tumour) [1].
Mammography and ultrasound are routinely used for the
workup of these lesions. Breast magnetic resonance imaging
(MRI) is being used increasingly, and it commonly demon-
strates fibroepithelial lesions. The clinical significance of these
lesions is that, although most of these lesions will require only
conservativemanagement, a small number (phyllodes tumour)
will require wide local excision given their potential for
recurrence or metastases. Imaging-guided core biopsy is
a standard procedure for the accurate diagnosis of breast
lesions. The radiologist is required to be familiar with the
imaging and histologic features of fibroepithelial lesions to
assess radiology-pathology correlation. The purpose of this
pictorial essay is to illustrate the role of imaging in the
recognition of these lesions, emphasize the importance of
clinical correlation, and identify certain imaging features that
may assist in differential diagnosis and management.Lactational Adenoma
Palpable breast masses are not infrequently encountered
during late pregnancy or the lactating period. Ultrasound is
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majority of solid breast masses in pregnant women [2]. They
tend to be soft, mobile small masses, usually smaller than
3 cm. Infrequently, they can present as a large firm mass, and
raise concern for malignancy. Lactational adenomas are
usually a straightforward histopathologic diagnosis.
Ultrasound appearances of lactational adenoma can be
variable; however, in general, findings are benign. Most are
oval, well-circumscribed homogeneous hypo- to isoechoic
masses (Figure 1A). Milk may become inspissated within
dilated acini and, given their proteinaceous and fatty nature,
may appear hyperechoic (Figure 2). Echogenic septations are
often present, and the majority of these lesions demonstrate
posterior acoustic enhancement because of fluid within acinar
lumina. They may be slightly compressible. Less commonly,
these lesions may have irregular borders with acoustic shad-
owing that can be mistaken for malignancy.
Because imaging features are nondiagnostic, fine needle
aspiration is recommended for all solid lesions diagnosed in
pregnancy, because, although infrequent, breast carcinoma
may occur. It is important to inform the pathologist that the
patient is pregnant or lactating. Core biopsy is indicated if
fine needle aspiration is inconclusive, although is not per-
formed initially because of the theoretical risk of milk fistula
formation. Lactational adenomas usually resolve at delivery
or cessation of lactation (Figure 1B).Tubular Adenoma
Tubular adenoma is a rare benign lesion of the breast,
mainly found in young women, although can occur in women
of all ages. They present as firm, circumscribed masses on
gross pathology. On histologic examination, tubular adenomas
consist of tightly packed tubules with a paucity of stroma seen
around the tubules.ll rights reserved.
Figure 1. (A) Lactational adenoma. Real-time sonography in a 26-week preg-
nant 25-year-old womanwith a palpable left breast mass, demonstrating a well-
circumscribed oval mass with echogenic septations (thin arrow) and posterior
acoustic enhancement (arrowheads). (B) Lactational adenoma. Follow-up
sonography of the same woman 10 months later reveals a much smaller mass
(asterisk) of similar echotexture to the surrounding breast parenchyma.
Figure 2. Lactational adenoma. Ultrasound in a 25-year-old lactating
woman, showing a palpable lactating adenoma within the left breast, with
large areas of hyperechogenicity (arrow) as a result of the proteinaceous and
fatty elements within inspissated milk.
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tubular adenomas. Their study showed noncalcified, well-
defined, solid masses that were mammographically and
sonographically similar to fibroadenomas in a relatively
younger group of patients (mean age, 29 years) (Figures 3Figure 3. Tubular adenoma. Sonography of the right breast in the sagittal a
circumscribed, homogeneous hypoechoic mass (asterisks) indistinguishable fromand 4), while a less common imaging finding of suspicious
ill-defined masses with associated microcalcifications were
seen in a relatively older population (mean age, 45 years),
although the 2 groups did show considerable age overlap. On
mammography, these microcalcifications are tightly packed,
dense, punctuate, and irregular, which represent calcifications
in inspissated secretions within dilated acinar glands. Core
biopsy of these lesions is essential to exclude a malignant
process, however, recognition of these imaging findings will
assist in confirming concordance between imaging and histo-
logic results and avoid unnecessary excisional biopsy.nd transverse planes in a 40-year-old woman, revealing an ovoid, well-
fibroadenomas.
Figure 4. Tubular adenoma. Right mediolateral oblique mammogram in
a 40-year-old woman with a palpable breast mass, showing a noncalcified
mostly circumscribed mass (arrow) adjacent to a metallic BB marker in
a heterogeneously dense breast. Figure 5. Fibroadenoma: Right mediolateral oblique mammogram in a 41-
year-old woman, demonstrating a palpable isodense macrolobulated cir-
cumscribed mass (asterisk) in the upper half of the breast.
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Fibroadenoma of the breast is the most common benign
breast neoplasm. Goehring and Morabia [4] reported an inci-
dence peak at 20e24 years, decreasing regularly until 45e49
years, with a steady low incidence seen in older womenwho are
usually on hormone replacement therapy. The overall preva-
lence of fibroadenoma is 15%e23% at autopsy [4]. The prev-
alence of fibroadenoma may be higher in black women
compared with white women [5]. An association of cyclosporin
Awith the development of fibroadenomas has been reported in
the literature [6].
On histologic examination, fibroadenomas arise from the
terminal duct lobular unit and develop as a result of combined
growth of epithelial and stromal elements in varying amounts.
After menopause, there is hyalinization of the stromal compo-
nent and regression of the epithelial elements. On gross exam-
ination, they have a white cut surface and are clearly delineated
from the surrounding breast [1].
When palpable, they present as a firm mobile mass and
may be multiple in up to 20% of patients [1]. They are
hormonally responsive and can undergo cyclic changes insize, with associated tenderness. In a study of acceptable
growth rates at long-term follow-up of fibroadenomas, Gor-
don et al [7] reported that fibroadenomas may be safely
followed up, with volume growth rates of up to 15% per
month, equivalent to a 20% increase in all 3 dimensions in
a 6-month period for all ages. Fibroadenomas typically
increase in size during pregnancy and lactation, and involute
in menopause because of a loss of hormonal support. Most
fibroadenomas cease growth at 2e3 cm [8].
On mammography, fibroadenoma presents as a well-
circumscribed round, oval, or macrolobulated mass that is
low to isodense to breast parenchyma (Figure 5). It does not
infiltrate the surrounding breast parenchyma and frequently
may be surrounded by a thin lucent halo because of the Mach
effect. For all practical purposes, it is indistinguishable from
a cyst or even a well-differentiated carcinoma, and further
evaluation with ultrasound is required. If they undergo invo-
lution, they often calcify. Characteristically, benign calcifica-
tions within fibroadenomas are dense and coarse, occur at the
periphery in the early stages (Figure 6), and coalesce over time,
Figure 6. Involuting fibroadenoma. Left magnification mediolateral view,
showing early degeneration of a fibroadenoma with very small, peripherally
distributed calcifications (arrow).
Figure 7. Involuting fibroadenomas in various stages of calcification. Routine
screening right breast mediolateral oblique mammogram in a 57-year-old
woman, showing coarse, dense popcorn-type calcifications with associated
masses (arrows).
Figure 8. Fibroadenoma. Left breast ultrasound in a 22-year-old woman,
revealing a well-circumscribed oval homogeneous hypoechoic mass with
echogenic ‘‘pseudocapsule’’ (curved arrow).
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require further workup. Early in the course of involution,
however, dystrophic calcifications may be very small, and it
may be difficult to distinguish these from granular and pleo-
morphic calcifications associatedwithmalignancy, and biopsy
will be required for further evaluation.
Most fibroadenomas are sonographically benign; oval in
shape, homogeneous hypo- to isoechoic well circumscribed
masseswith the long axis parallel to the skin surface (Figure 8).
An internal finding that is rather typical of fibroadenoma is the
internal fibrous septation that may be seen as thin, nearly
straight echogenic lines traversing the interior and usually
extending out to the capsule on one surface of the fibroade-
noma [9], analogous to the nonenhancing internal fibrousFigure 9. Involuting fibroadenoma. Left breast ultrasound in a 40-year-old
woman, revealing a heterogeneous well-circumscribed hypoechoic mass
with internal foci of echogenicity in keeping with dystrophic calcification
(arrow).
Figure 10. (A) Fibroadenoma. Real-time sonography of a palpable lump in
the left breast of a 23-year-old woman; an oval homogeneous, wider than tall
hypoechoic mass with a thin echogenic capsule is seen. Power Doppler
sonography reveals the presence of a segmental vessel (arrow) located within
the fibrous septa of the lesion. (B) Fibroadenoma. Power Doppler sonog-
raphy in a 17-year-old woman of a fibroadenoma in the left breast shows
a capsular vessel (arrow). (C) Fibroadenoma. Power Doppler sonography in
the same 17-year-old woman of a different fibroadenoma in the left breast,
showing a feeding vessel (arrow).
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tissue may be compressed and form an ‘‘echogenic’’ pseudo-
capsule. Heterogeneous echotexture, a finding caused by
necrosis or dystrophic calcification, is more common in older
women (Figure 9) [10]. Approximately 80% of fibroadenomas
demonstrate blood flow on colour Doppler sonography, with
vascularization of fibroadenomas being more extensive and
evident in young patients on sonography than in older patients
because of a higher incidence of sclerosed fibroadenomas in
the latter population [11]. Three vessel types having been
described [11]: feeding vessels, which are prominent vessels
that lead from the surrounding breast tissue into the fibroade-
noma; capsular vessels, which are located within the tissue
capsule; and segmental vessels, which are located within the
fibrous septa of the fibroadenoma (Figure 10). Posterior
acoustic enhancement is variable; fibroadenomas that contain
a greater epithelial component typically demonstrate
increased through transmission, whereas hyalinized or largely
calcified masses demonstrate posterior shadowing [8].
Unfortunately, not all fibroadenomas have classic imaging
appearances, and a small percentage may havemicrolobulated
or irregular margins (Figure 11). These will require biopsy to
confirm their benign nature.
On MRI, the appearance of fibroadenomas varies with the
amount of hyalinization. Myxoid fibroadenomas are low
signal on noncontrast T1 images and typically high signal on
T2 sequences (Figure 12). Sclerotic fibroadenomas have very
low signal on T2-weighted sequences. As on other imaging
modalities, fibroadenomas show well-circumscribed margins
and are usually round, oval, or lobulated. Cellular fibroade-
nomas demonstrate rapid, uniform homogeneous enhance-
ment, whereas hyalinized fibroadenomas may haveweak to noFigure 11. Fibroadenoma. Newly palpable right breast mass in a 44-year-old
woman; ultrasound shows a hypoechoic mass with microlobulations
(asterisk); this finding mandates biopsy to exclude malignancy.
Figure 12. (AeE) Fibroadenoma in a 50-year-old woman who is at high risk for breast cancer, undergoing annual mammographic and magnetic resonance
imaging surveillance. (A) Right craniocaudal (CC) mammogram, revealing a well-circumscribed macrolobulated mass (arrow) in the medial half of the breast.
(B) Sonography, revealing an oval, well-circumscribed hypoechoic lesion (asterisk) with abrupt interface to the surrounding breast parenchyma. (C) Axial
precontrast T1-weighted image, showing a well-circumscribed mass (arrow) that is hypointense to fat (asterisk) and isointense to fibroglandular tissue. (D)
Sagittal postcontrast fat saturation T2-weighted image, the mass (arrow) is high signal, reflecting its largely myxoid composition. Internal areas of low signal
are likely in keeping with areas of hyalinization. (E) Postcontrast T1 fat-saturation image obtained 6 minutes after gadolinium, demonstrating avid homo-
geneous enhancement of the lesion (arrow), which demonstrated persistent kinetics.
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Figure 13. (A) Juvenile fibroadenoma. Ultrasound of an oval, well-
circumscribed palpable mass in a 19-year-old woman which could not be
imaged in a single view given the large size of the mass (arrowheads). These
lesions are indistinguishable from fibroadenomas in older women on imaging.
(B) Juvenile fibroadenoma. Left mediolateral oblique (MLO) view in the same
patient, showing a large mass that occupies much of the lower left breast.
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nomata contain nonenhancing internal septations, which if
seen, are diagnostic for benign fibroadenoma to >95%
certainty [12]. This finding correlates with collagenous bands
within the tumour on histopathologic examination [13].VariantsJuvenile FibroadenomaJuvenile fibroadenoma is an uncommon variant character-
ized clinically by markedly rapid growth and histologically by
hypercellular stromal proliferation. About 7%e8% of fibroa-
denomas in adolescence fall into this category [14]. Juvenile
fibroadenomas most often occur in African American
adolescent girls, who are also more likely to have multiple and
bilateral tumours at presentation [14].Apart from the age of the
patient, their larger size and stromal hypercellularity, these
lesions cannot be distinguished from fibroadenomas seen in
older women on imaging (Figure 13, A and B). Because of
their large size, distended superficial veins or, occasionally,
skin ulceration may be seen. In contrast to typical fibroade-
nomas, however, juvenile fibroadenomas are usually treated
with excision, given their rapid growth.Complex FibroadenomaComplex fibroadenoma was first described by Dupont et al
[15] as fibroadenomas with cysts, sclerosing adenosis,
epithelial calcifications or papillary apocrine changes. Their
significance is underlined by the finding that the risk of inva-
sive breast cancer in patients with complex fibroadenomas was
3.1 times higher than in women of the general population,
compared with a relative risk of 1.89 for noncomplex fibroa-
denomas [15].
Furthermore, Dupont et al [15] reported that the elevated
risk of breast carcinoma in patients with this diagnosis remains
elevated indefinitely after the diagnosis and is increased
further in patients who also have the following: benign
proliferative disease in adjacent parenchyma or a family
history of breast carcinoma. The increase in relative risk is for
the entirety of both breasts, not limited to the site of the
fibroadenoma.
Sonographic findings suggestive of complex fibroadenoma
within solid nodules include small punctuate echogenicities
(Figure 14A) because of epithelial calcifications, which are
usually too small to cause acoustic shadowing. Internal cysts
are also frequently present, related to apocrine metaplasia
(Figure 14B). Heterogeneous echotexture may be the only
findings in nodules in which discrete cysts or punctuate
echogenic foci are not identifiable.
Awareness of this entity is important because the presence of
changes within a solid nodule that suggests complex rather than
simple fibroadenoma may motivate biopsy instead of routine
follow-up in a nodule that would otherwise be classified as
BIRADS 3 sonographically, given the possible long-term
follow-up implications of a diagnosis of complex fibroade-
noma.There is limited literature on themanagement of complex
fibroadenomas. Sklair-Levy et al [16] found a low incidence of
malignancy in complex fibroadenomas at amean follow-up of 2
years in their study population of 63 patients and recommend
that women with complex fibroadenomas be managed conser-
vatively, with the same approach as for simple fibroadenomas.
Figure 14. (A) Complex fibroadenoma. Ultrasound of the right breast in a 35-year-old woman; tiny foci of echogenicity (arrow) are seen within this lesion,
likely representing epithelial calcifications. (B) Complex fibroadenoma. Ultrasound of the right breast in a 35-year-old woman: Well-circumscribed, thin-
walled cysts (arrow) are seen within this solid nodule, which suggests the presence of apocrine metaplasia.
Figure 15. Benign phyllodes tumour. A 50-year-old woman presenting with
a rapidly enlarging palpable right breast lump. Right craniocaudal
mammogram, showing a dense noncalcified mass, with well-circumscribed
macrolobulated margins (arrow).
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Phyllodes tumour is an uncommon breast tumour. It
accounts for fewer than 1% of all breast tumours and 2%e3%
of fibroepithelial lesions of the breast [17]. Phyllodes tumour
occurs most frequently in women between the ages of 45e49
years, about 20 years later than the peak incidence of fibroa-
denomas [18]. Age patterns vary by ethnicity, with Asian
patients significantly younger at presentation [18]. Clinically,
theymost commonly present as a painless, palpable lump,with
a history of rapid enlargement over a short period of time from
detection. If the tumour is very large, then fixation to the
underlying chest wall or ulceration of the overlying skin may
occur.
On histopathologic examination, these tumours are char-
acterized by higher stromal cellularity than fibroadenomas.
The stroma is markedly expanded and grows into the ducts,
resulting in the formation of leaflike processes pathogno-
monic of this tumour. They can be classified as benign,
borderline, and malignant, and this subclassification
continues to be followed today [19]. The malignant charac-
teristics of these lesions are based on the stromal findings.
No prior studies have managed to establish imaging criteria
that can differentiate benign from malignant phyllodes
tumour [17,20].
On mammography, appearances are nonspecific, and they
appear as dense round or oval masses with well-circumscribed
or lobulated borders (Figure 15). Ill-defined margins may be
seen in locally aggressive lesions. Calcification is rare possibly
because of their relatively rapid growth rate but may be seen
and, when present, are usually large and coarse (Figure 16A).
The only feature that has been associated with a higher like-
lihood of malignancy is a tumour diameter of 3 cm or larger
(Figure 16B) [17]. On sonography, they are solid hypoechoicnodules, which, in most cases, are well circumscribed. The
high stromal cellularity of these lesions commonly results in
posterior acoustic enhancement. Intralesional cystic spaces
may also be seen, which are most commonly flattened or
Figure 16. (A) Malignant phyllodes tumour. Axial post contrast computed
tomography imaging through the breasts of a 37-year-old woman, showing
a large mass replacing the right breast that contains large coarse calcifica-
tions (arrows). (B) Malignant phyllodes tumour. Real-time sonogram of the
right breast in the same patient; the tumour could not be imaged on a single
view given its large size; large cystic spaces (asterisk) and marked internal
heterogeneity consistent with large areas of cystic necrosis.
Figure 17. Benign phyllodes tumour: ultrasound of the left breast in a 38-
year-old woman, revealing a well-circumscribed, hypoechoic mass that
contains cystic spaces that are flat and slitlike (arrow).
Figure 18. Benign phyllodes tumour: ultrasound of a palpable left breast
lump in a 41-year-old woman, revealing a hypoechoic heterogeneous mass
with internal cleftlike cystic spaces orientated in all directions (arrowheads),
with posterior acoustic enhancement (arrows).
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18). These cystic spaces correspond to cystic necrosis, which,
when present, suggests a diagnosis of phyllodes tumour [10].
Fluid-filled clefts within the tumour will appear as linear
echoes orientated perpendicular to the beamwhen they are too
narrow to be resolved by ultrasound [21]. Vascularity is
common with colour Doppler sonography.
Phyllodes tumours most commonly demonstrate a round or
lobulated shape with well-defined margins on MRI (Figure 19).
They are usually low signal intensity on T1, although the pres-
ence of intratumoural hemorrhage will result in an increased T1
signal. A small percentage of phyllodes tumours may showbright cystic spaces within the tumour on T2-weighted
sequences. All 3 types of contrast enhancement patterns are
seenwith phyllodes tumours, and theymay show nonenhancing,
low T2 signal septations similar to fibroadenomas [22]. Yabuu-
chi et al [20] reported that several magnetic resonance findings,
including cystic change with irregular wall (necrosis), tumour
Figure 19. (AeE) Benign phyllodes tumour: new rapidly growing palpable mass in a 46-year-old woman. (A) Right mediolateral oblique (MLO) mammogram,
demonstrating a well-circumscribed mass (arrow) in the axillary tail of the right breast. (B) Sonography, revealing a well-circumscribed hypoechoic mass, with
multiple horizontal linear echoes that represent fluid-filled clefts that are too narrow to resolve sonographically (curved arrow). (C) Axial precontrast T1-
weighted image, showing a well-circumscribed mass (arrow) that is hypointense to fat (asterisk) and isointense to fibroglandular tissue. (D) Sagittal post-
contrast fat saturation T2-weighted image, showing the lesion with heterogeneous internal signal and low signal septations (arrow). (E) Postcontrast T1 image
subtracted obtained 2 minutes after gadolinium, demonstrating a heterogeneously enhancing mass with nonenhancing septations (arrowhead).
144 B. Chu, P. Crystal / Canadian Association of Radiologists Journal 63 (2012) 135e145
145Imaging of fibroepithelial lesions / Canadian Association of Radiologists Journal 63 (2012) 135e145signal intensity lower than or equal to normal breast tissue signal
intensity on T2-weighted images and/or low apparent diffusion
coefficient (ADC) on diffusion-weighted images (stromal
hypercellularity) are suggestive of histopathologicallymalignant
phyllodes tumour. MRI cannot precisely differentiate phyllodes
tumours from fibroadenomas, although phyllodes tumours are
more likely to be associated with increased T2 signal in the
surrounding breast tissue [22].
Treatment for phyllodes tumour is wide local excision to
reduce the incidence of local recurrence. Adjuvant radio-
therapy may be used as an adjunct. Mastectomy may be
required for very large tumours if the tumour to breast ratio is
sufficiently high. Hematogenous tumour spread to lung and
bone are most common, with lymphatic spread to axillary
nodes rare. Barrio et al [23] reported a 10-year actuarial local
recurrence rate of 14% for phyllodes tumours, whereas
malignant phyllodes did not have a higher risk of local
recurrence. Recurrence has been associated with incomplete
surgical excision; fibroproliferation in surrounding breast
tissue and tumour necrosis [23].
Conclusion
Fibroepithelial lesions are common in breast imaging, with
fibroadenoma the most common lesion in this group. Knowl-
edge of the clinical, pathologic, and imaging features allows the
radiologist to accurately diagnose and appropriately manage
these lesions. These lesions may not always be distinguishable
from carcinoma, and tissue sampling may be required for final
diagnosis. The majority of these lesions can be managed
conservatively, although juvenile fibroadenomas may require
surgical excision for symptom control, and phyllodes tumour
requires wide local excision to prevent local recurrence.
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